Cargando…
Oligomeric state of the ZIKV E protein defines protective immune responses
The current leading Zika vaccine candidates in clinical testing are based on live or killed virus platforms, which have safety issues, especially in pregnant women. Zika subunit vaccines, however, have shown poor performance in preclinical studies, most likely because the antigens tested do not disp...
Autores principales: | Metz, Stefan W., Thomas, Ashlie, Brackbill, Alex, Forsberg, John, Miley, Michael J., Lopez, Cesar A., Lazear, Helen M., Tian, Shaomin, de Silva, Aravinda M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6787251/ https://www.ncbi.nlm.nih.gov/pubmed/31601808 http://dx.doi.org/10.1038/s41467-019-12677-6 |
Ejemplares similares
-
Nanoparticle delivery of a tetravalent E protein subunit vaccine induces balanced, type-specific neutralizing antibodies to each dengue virus serotype
por: Metz, Stefan W., et al.
Publicado: (2018) -
In Vitro Assembly and Stabilization of Dengue and Zika Virus Envelope Protein Homo-Dimers
por: Metz, Stefan W., et al.
Publicado: (2017) -
Precisely Molded Nanoparticle Displaying DENV-E Proteins Induces Robust Serotype-Specific Neutralizing Antibody Responses
por: Metz, Stefan W., et al.
Publicado: (2016) -
Study on the persistence of Zika virus (ZIKV) in body fluids of patients with ZIKV infection in Brazil
por: Calvet, Guilherme Amaral, et al.
Publicado: (2018) -
Identification of Inhibitors of ZIKV Replication
por: Morales Vasquez, Desarey, et al.
Publicado: (2020)